Clinical Trials Directory

Trials / Completed

CompletedNCT03501862

Mindfulness Intervention for People With Psychosis

Mindfulness-based Interventions for People With Recent-onset Psychosis: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
108 (actual)
Sponsor
The Hong Kong Polytechnic University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

People with psychosis demonstrated a tendency to use maladaptive cognitive emotion regulation strategies as compared with healthy control groups. The present study is the first randomized controlled trial of group mindfulness-based intervention for psychosis. Half group will join the mindfulness-based cognitive intervention while another half will participate in psychoeducation to examine whether mindfulness will have a positive impact on emotion regulation and distress.

Detailed description

Concurrently with positive and negative symptoms, affective symptoms and full affective disorder episodes are common in psychotic disorders particularly in the acute phase of illness. Affective symptoms are a significant risk factor accounting for approximately 5-6% of suicide rates which remain or becomes higher shortly after a psychotic episode or hospital discharge (American Psychiatric Association, 2013). It has been proved that the emotion management and cognitive reappraisal were negatively associated with schizophrenia. In the study, it is hypothesized that the intervention will have a positive impact on psychotic symptoms, general symptoms such as affective symptoms, psychological flexibility, mindfulness skills, quality of life and re-hospitalization by facilitating strategies on emotion regulation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness-based cognitive therapy (psychosis)A small group intervention is based on a structured and validated protocol that will include mindfulness practice, cognitive skills
BEHAVIORALPsychoeducation (psychosis)A small group intervention will be focusing on understanding of psychosis, treatment, relapse prevention and useful information and resources.

Timeline

Start date
2017-01-15
Primary completion
2021-07-31
Completion
2021-07-31
First posted
2018-04-18
Last updated
2021-09-27

Locations

2 sites across 2 countries: China, Hong Kong

Source: ClinicalTrials.gov record NCT03501862. Inclusion in this directory is not an endorsement.